Anxiety and substance use: layers of complexity (Q37111913)

18 August 2017

1 reference

title

Anxiety and substance use: layers of complexity (English)

1 reference

18 August 2017

0 references

David J Castle

1

1 reference

PubMed ID

18345977

18 August 2017

language of work or name

1 reference

1 March 2008

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

18 August 2017

1 reference

18 August 2017

8

1 reference

18 August 2017

3

1 reference

18 August 2017

493-501

1 reference

Drinking to cope in socially anxious individuals: a controlled study

18 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Suicidal ideation and suicide attempts in panic disorder and attacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

The long-term treatment outcomes of depression and anxiety comorbid with substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Panic disorder and suicide attempt. A reanalysis of data from the Epidemiologic Catchment Area study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: a family history study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Anxiety mediates the association between anxiety sensitivity and coping-related drinking motives in alcoholism treatment patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

A cognitive-behavioral treatment for incarcerated women with substance abuse disorder and posttraumatic stress disorder: findings from a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

"Transcend": initial outcomes from a posttraumatic stress disorder/substance abuse treatment program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

The treatment of substance abusers diagnosed with obsessive-compulsive disorder: an outcome study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Management of anxiety disorders: the added challenge of comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Pharmacologic treatments for drug and alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Anxiolytic-like properties of the anandamide transport inhibitor AM404.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Acute and subchronic effects of MDMA ("ecstasy") on anxiety in male mice tested in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Regional brain metabolic response to lorazepam in subjects at risk for alcoholism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Partial deletion of the cAMP response element-binding protein gene promotes alcohol-drinking behaviors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Central and medial amygdaloid brain-derived neurotrophic factor signaling plays a critical role in alcohol-drinking and anxiety-like behaviors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Neuropeptide y: role in emotion and alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

Galanin: a novel therapeutic target for depression, anxiety disorders and drug addiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.493

21 January 2018

Identifiers

DOI

10.1586/14737175.8.3.493

1 reference

18 August 2017

1 reference

PubMed ID

18345977